Literature DB >> 25528498

Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.

Alice W Lee1, Jonathan P Tyrer2, Jennifer A Doherty3, Douglas A Stram1, Jolanta Kupryjanczyk4, Agnieszka Dansonka-Mieszkowska4, Joanna Plisiecka-Halasa4, Beata Spiewankiewicz5, Emily J Myers1, Georgia Chenevix-Trench6, Peter A Fasching7, Matthias W Beckmann8, Arif B Ekici9, Alexander Hein8, Ignace Vergote10, Els Van Nieuwenhuysen10, Diether Lambrechts11, Kristine G Wicklund12, Ursula Eilber13, Shan Wang-Gohrke14, Jenny Chang-Claude13, Anja Rudolph13, Lara Sucheston-Campbell15, Kunle Odunsi16, Kirsten B Moysich15, Yurii B Shvetsov17, Pamela J Thompson18, Marc T Goodman18, Lynne R Wilkens17, Thilo Dörk19, Peter Hillemanns20, Matthias Dürst21, Ingo B Runnebaum21, Natalia Bogdanova19, Liisa M Pelttari22, Heli Nevanlinna22, Arto Leminen22, Robert P Edwards23, Joseph L Kelley24, Philipp Harter25, Ira Schwaab26, Florian Heitz25, Andreas du Bois25, Sandra Orsulic27, Jenny Lester27, Christine Walsh27, Beth Y Karlan27, Estrid Hogdall28, Susanne K Kjaer29, Allan Jensen30, Robert A Vierkant31, Julie M Cunningham32, Ellen L Goode31, Brooke L Fridley33, Melissa C Southey34, Graham G Giles35, Fiona Bruinsma36, Xifeng Wu37, Michelle A T Hildebrandt37, Karen Lu38, Dong Liang39, Maria Bisogna40, Douglas A Levine40, Rachel Palmieri Weber41, Joellen M Schildkraut42, Edwin S Iversen43, Andrew Berchuck44, Kathryn L Terry45, Daniel W Cramer45, Shelley S Tworoger46, Elizabeth M Poole46, Sara H Olson47, Irene Orlow47, Elisa V Bandera48, Line Bjorge49, Ingvild L Tangen49, Helga B Salvesen49, Camilla Krakstad49, Leon F A G Massuger50, Lambertus A Kiemeney51, Katja K H Aben52, Anne M van Altena50, Yukie Bean53, Tanja Pejovic53, Melissa Kellar53, Nhu D Le54, Linda S Cook55, Linda E Kelemen56, Angela Brooks-Wilson57, Jan Lubinski58, Jacek Gronwald58, Cezary Cybulski58, Anna Jakubowska58, Nicolas Wentzensen59, Louise A Brinton59, Jolanta Lissowska60, Hannah Yang59, Lotte Nedergaard61, Lene Lundvall62, Claus Hogdall62, Honglin Song2, Ian G Campbell63, Diana Eccles64, Rosalind Glasspool65, Nadeem Siddiqui66, Karen Carty65, James Paul65, Iain A McNeish67, Weiva Sieh68, Valerie McGuire68, Joseph H Rothstein68, Alice S Whittemore68, John R McLaughlin69, Harvey A Risch70, Catherine M Phelan71, Hoda Anton-Culver72, Argyrios Ziogas73, Usha Menon74, Susan J Ramus1, Aleksandra Gentry-Maharaj74, Patricia Harrington75, Malcolm C Pike76, Francesmary Modugno77, Mary Anne Rossing78, Roberta B Ness79, Paul D P Pharoah80, Daniel O Stram1, Anna H Wu1, Celeste Leigh Pearce81.   

Abstract

OBJECTIVE: Ovarian cancer is a hormone-related disease with a strong genetic basis. However, none of its high-penetrance susceptibility genes and GWAS-identified variants to date are known to be involved in hormonal pathways. Given the hypothesized etiologic role of gonadotropins, an assessment of how variability in genes involved in the gonadotropin signaling pathway impacts disease risk is warranted.
METHODS: Genetic data from 41 ovarian cancer study sites were pooled and unconditional logistic regression was used to evaluate whether any of the 2185 SNPs from 11 gonadotropin signaling pathway genes was associated with ovarian cancer risk. A burden test using the admixture likelihood (AML) method was also used to evaluate gene-level associations.
RESULTS: We did not find any genome-wide significant associations between individual SNPs and ovarian cancer risk. However, there was some suggestion of gene-level associations for four gonadotropin signaling pathway genes: INHBB (p=0.045, mucinous), LHCGR (p=0.046, high-grade serous), GNRH (p=0.041, high-grade serous), and FSHB (p=0.036, overall invasive). There was also suggestive evidence for INHA (p=0.060, overall invasive).
CONCLUSIONS: Ovarian cancer studies have limited sample numbers, thus fewer genome-wide susceptibility alleles, with only modest associations, have been identified relative to breast and prostate cancers. We have evaluated the majority of ovarian cancer studies with biological samples, to our knowledge, leaving no opportunity for replication. Using both our understanding of biology and powerful gene-level tests, we have identified four putative ovarian cancer loci near INHBB, LHCGR, GNRH, and FSHB that warrant a second look if larger sample sizes and denser genotype chips become available.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gene; Genetic variation; Genetics; Gonadotropins; Ovarian cancer; Polymorphisms

Mesh:

Substances:

Year:  2014        PMID: 25528498      PMCID: PMC4892108          DOI: 10.1016/j.ygyno.2014.12.017

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  31 in total

Review 1.  Combined adult granulosa cell tumor and mucinous cystadenoma of the ovary: granulosa cell tumor with heterologous mucinous elements.

Authors:  Michael McKenna; Brian Kenny; Gary Dorman; W Glenn McCluggage
Journal:  Int J Gynecol Pathol       Date:  2005-07       Impact factor: 2.762

2.  Estimating local ancestry in admixed populations.

Authors:  Sriram Sankararaman; Srinath Sridhar; Gad Kimmel; Eran Halperin
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

3.  Peritoneal fluid gonadotropins and ovarian hormones in patients with ovarian cancer.

Authors:  R. Halperin; E. Hadas; R. Langer; I. Bukovsky; D. Schneider
Journal:  Int J Gynecol Cancer       Date:  1999-11       Impact factor: 3.437

4.  A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

Authors:  Ellen L Goode; Georgia Chenevix-Trench; Honglin Song; Susan J Ramus; Maria Notaridou; Kate Lawrenson; Martin Widschwendter; Robert A Vierkant; Melissa C Larson; Susanne K Kjaer; Michael J Birrer; Andrew Berchuck; Joellen Schildkraut; Ian Tomlinson; Lambertus A Kiemeney; Linda S Cook; Jacek Gronwald; Montserrat Garcia-Closas; Martin E Gore; Ian Campbell; Alice S Whittemore; Rebecca Sutphen; Catherine Phelan; Hoda Anton-Culver; Celeste Leigh Pearce; Diether Lambrechts; Mary Anne Rossing; Jenny Chang-Claude; Kirsten B Moysich; Marc T Goodman; Thilo Dörk; Heli Nevanlinna; Roberta B Ness; Thorunn Rafnar; Claus Hogdall; Estrid Hogdall; Brooke L Fridley; Julie M Cunningham; Weiva Sieh; Valerie McGuire; Andrew K Godwin; Daniel W Cramer; Dena Hernandez; Douglas Levine; Karen Lu; Edwin S Iversen; Rachel T Palmieri; Richard Houlston; Anne M van Altena; Katja K H Aben; Leon F A G Massuger; Angela Brooks-Wilson; Linda E Kelemen; Nhu D Le; Anna Jakubowska; Jan Lubinski; Krzysztof Medrek; Anne Stafford; Douglas F Easton; Jonathan Tyrer; Kelly L Bolton; Patricia Harrington; Diana Eccles; Ann Chen; Ashley N Molina; Barbara N Davila; Hector Arango; Ya-Yu Tsai; Zhihua Chen; Harvey A Risch; John McLaughlin; Steven A Narod; Argyrios Ziogas; Wendy Brewster; Aleksandra Gentry-Maharaj; Usha Menon; Anna H Wu; Daniel O Stram; Malcolm C Pike; Jonathan Beesley; Penelope M Webb; Xiaoqing Chen; Arif B Ekici; Falk C Thiel; Matthias W Beckmann; Hannah Yang; Nicolas Wentzensen; Jolanta Lissowska; Peter A Fasching; Evelyn Despierre; Frederic Amant; Ignace Vergote; Jennifer Doherty; Rebecca Hein; Shan Wang-Gohrke; Galina Lurie; Michael E Carney; Pamela J Thompson; Ingo Runnebaum; Peter Hillemanns; Matthias Dürst; Natalia Antonenkova; Natalia Bogdanova; Arto Leminen; Ralf Butzow; Tuomas Heikkinen; Kari Stefansson; Patrick Sulem; Sören Besenbacher; Thomas A Sellers; Simon A Gayther; Paul D P Pharoah
Journal:  Nat Genet       Date:  2010-09-19       Impact factor: 38.330

5.  The haplotype of two FSHR polymorphisms in ovarian cancer--a potential role of ethnology in risk modification.

Authors:  Martin Heubner; Kathrin Riemann; Friedrich Otterbach; Rainer Kimmig; Sabine Kasimir-Bauer; Winfried Siffert; Pauline Wimberger
Journal:  Gynecol Oncol       Date:  2009-01-15       Impact factor: 5.482

6.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing.

Authors:  Bryan Howie; Christian Fuchsberger; Matthew Stephens; Jonathan Marchini; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2012-07-22       Impact factor: 38.330

7.  Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.

Authors:  Fergus J Couch; Xianshu Wang; Lesley McGuffog; Andrew Lee; Curtis Olswold; Karoline B Kuchenbaecker; Penny Soucy; Zachary Fredericksen; Daniel Barrowdale; Joe Dennis; Mia M Gaudet; Ed Dicks; Matthew Kosel; Sue Healey; Olga M Sinilnikova; Adam Lee; François Bacot; Daniel Vincent; Frans B L Hogervorst; Susan Peock; Dominique Stoppa-Lyonnet; Anna Jakubowska; Paolo Radice; Rita Katharina Schmutzler; Susan M Domchek; Marion Piedmonte; Christian F Singer; Eitan Friedman; Mads Thomassen; Thomas V O Hansen; Susan L Neuhausen; Csilla I Szabo; Ignacio Blanco; Mark H Greene; Beth Y Karlan; Judy Garber; Catherine M Phelan; Jeffrey N Weitzel; Marco Montagna; Edith Olah; Irene L Andrulis; Andrew K Godwin; Drakoulis Yannoukakos; David E Goldgar; Trinidad Caldes; Heli Nevanlinna; Ana Osorio; Mary Beth Terry; Mary B Daly; Elizabeth J van Rensburg; Ute Hamann; Susan J Ramus; Amanda Ewart Toland; Maria A Caligo; Olufunmilayo I Olopade; Nadine Tung; Kathleen Claes; Mary S Beattie; Melissa C Southey; Evgeny N Imyanitov; Marc Tischkowitz; Ramunas Janavicius; Esther M John; Ava Kwong; Orland Diez; Judith Balmaña; Rosa B Barkardottir; Banu K Arun; Gad Rennert; Soo-Hwang Teo; Patricia A Ganz; Ian Campbell; Annemarie H van der Hout; Carolien H M van Deurzen; Caroline Seynaeve; Encarna B Gómez Garcia; Flora E van Leeuwen; Hanne E J Meijers-Heijboer; Johannes J P Gille; Margreet G E M Ausems; Marinus J Blok; Marjolijn J L Ligtenberg; Matti A Rookus; Peter Devilee; Senno Verhoef; Theo A M van Os; Juul T Wijnen; Debra Frost; Steve Ellis; Elena Fineberg; Radka Platte; D Gareth Evans; Louise Izatt; Rosalind A Eeles; Julian Adlard; Diana M Eccles; Jackie Cook; Carole Brewer; Fiona Douglas; Shirley Hodgson; Patrick J Morrison; Lucy E Side; Alan Donaldson; Catherine Houghton; Mark T Rogers; Huw Dorkins; Jacqueline Eason; Helen Gregory; Emma McCann; Alex Murray; Alain Calender; Agnès Hardouin; Pascaline Berthet; Capucine Delnatte; Catherine Nogues; Christine Lasset; Claude Houdayer; Dominique Leroux; Etienne Rouleau; Fabienne Prieur; Francesca Damiola; Hagay Sobol; Isabelle Coupier; Laurence Venat-Bouvet; Laurent Castera; Marion Gauthier-Villars; Mélanie Léoné; Pascal Pujol; Sylvie Mazoyer; Yves-Jean Bignon; Elżbieta Złowocka-Perłowska; Jacek Gronwald; Jan Lubinski; Katarzyna Durda; Katarzyna Jaworska; Tomasz Huzarski; Amanda B Spurdle; Alessandra Viel; Bernard Peissel; Bernardo Bonanni; Giulia Melloni; Laura Ottini; Laura Papi; Liliana Varesco; Maria Grazia Tibiletti; Paolo Peterlongo; Sara Volorio; Siranoush Manoukian; Valeria Pensotti; Norbert Arnold; Christoph Engel; Helmut Deissler; Dorothea Gadzicki; Andrea Gehrig; Karin Kast; Kerstin Rhiem; Alfons Meindl; Dieter Niederacher; Nina Ditsch; Hansjoerg Plendl; Sabine Preisler-Adams; Stefanie Engert; Christian Sutter; Raymonda Varon-Mateeva; Barbara Wappenschmidt; Bernhard H F Weber; Brita Arver; Marie Stenmark-Askmalm; Niklas Loman; Richard Rosenquist; Zakaria Einbeigi; Katherine L Nathanson; Timothy R Rebbeck; Stephanie V Blank; David E Cohn; Gustavo C Rodriguez; Laurie Small; Michael Friedlander; Victoria L Bae-Jump; Anneliese Fink-Retter; Christine Rappaport; Daphne Gschwantler-Kaulich; Georg Pfeiler; Muy-Kheng Tea; Noralane M Lindor; Bella Kaufman; Shani Shimon Paluch; Yael Laitman; Anne-Bine Skytte; Anne-Marie Gerdes; Inge Sokilde Pedersen; Sanne Traasdahl Moeller; Torben A Kruse; Uffe Birk Jensen; Joseph Vijai; Kara Sarrel; Mark Robson; Noah Kauff; Anna Marie Mulligan; Gord Glendon; Hilmi Ozcelik; Bent Ejlertsen; Finn C Nielsen; Lars Jønson; Mette K Andersen; Yuan Chun Ding; Linda Steele; Lenka Foretova; Alex Teulé; Conxi Lazaro; Joan Brunet; Miquel Angel Pujana; Phuong L Mai; Jennifer T Loud; Christine Walsh; Jenny Lester; Sandra Orsulic; Steven A Narod; Josef Herzog; Sharon R Sand; Silvia Tognazzo; Simona Agata; Tibor Vaszko; Joellen Weaver; Alexandra V Stavropoulou; Saundra S Buys; Atocha Romero; Miguel de la Hoya; Kristiina Aittomäki; Taru A Muranen; Mercedes Duran; Wendy K Chung; Adriana Lasa; Cecilia M Dorfling; Alexander Miron; Javier Benitez; Leigha Senter; Dezheng Huo; Salina B Chan; Anna P Sokolenko; Jocelyne Chiquette; Laima Tihomirova; Tara M Friebel; Bjarni A Agnarsson; Karen H Lu; Flavio Lejbkowicz; Paul A James; Per Hall; Alison M Dunning; Daniel Tessier; Julie Cunningham; Susan L Slager; Chen Wang; Steven Hart; Kristen Stevens; Jacques Simard; Tomi Pastinen; Vernon S Pankratz; Kenneth Offit; Douglas F Easton; Georgia Chenevix-Trench; Antonis C Antoniou
Journal:  PLoS Genet       Date:  2013-03-27       Impact factor: 5.917

8.  Genotype imputation with thousands of genomes.

Authors:  Bryan Howie; Jonathan Marchini; Matthew Stephens
Journal:  G3 (Bethesda)       Date:  2011-11-01       Impact factor: 3.154

9.  Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation.

Authors:  Travis J O'Brien; Mariah M Kalmin; Arthur F Harralson; Adam M Clark; Ian Gindoff; Samuel J Simmens; David Frankfurter; Paul Gindoff
Journal:  Reprod Biol Endocrinol       Date:  2013-07-25       Impact factor: 5.211

Review 10.  Fertility drugs, reproductive strategies and ovarian cancer risk.

Authors:  Federica Tomao; Giuseppe Lo Russo; Gian Paolo Spinelli; Valeria Stati; Alessandra Anna Prete; Natalie Prinzi; Marsela Sinjari; Patrizia Vici; Anselmo Papa; Maria Stefania Chiotti; Pierluigi Benedetti Panici; Silverio Tomao
Journal:  J Ovarian Res       Date:  2014-05-08       Impact factor: 4.234

View more
  7 in total

1.  Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.

Authors:  Brett M Reid; Jennifer B Permuth; Y Ann Chen; Brooke L Fridley; Edwin S Iversen; Zhihua Chen; Heather Jim; Robert A Vierkant; Julie M Cunningham; Jill S Barnholtz-Sloan; Steven Narod; Harvey Risch; Joellen M Schildkraut; Ellen L Goode; Alvaro N Monteiro; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-04-04       Impact factor: 4.254

2.  Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank.

Authors:  Sarah R Irvin; Elisabete Weiderpass; Frank Z Stanczyk; Louise A Brinton; Britton Trabert; Hilde Langseth; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-01-13       Impact factor: 4.254

3.  Systematic review and meta-analysis of studies assessing the relationship between statin use and risk of ovarian cancer.

Authors:  Sarah Irvin; Megan A Clarke; Britton Trabert; Nicolas Wentzensen
Journal:  Cancer Causes Control       Date:  2020-07-20       Impact factor: 2.506

Review 4.  Mechanisms of High-Grade Serous Carcinogenesis in the Fallopian Tube and Ovary: Current Hypotheses, Etiologic Factors, and Molecular Alterations.

Authors:  Isao Otsuka
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

5.  Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.

Authors:  Shalaka S Hampras; Lara E Sucheston-Campbell; Rikki Cannioto; Jenny Chang-Claude; Francesmary Modugno; Thilo Dörk; Peter Hillemanns; Leah Preus; Keith L Knutson; Paul K Wallace; Chi-Chen Hong; Grace Friel; Warren Davis; Mary Nesline; Celeste L Pearce; Linda E Kelemen; Marc T Goodman; Elisa V Bandera; Kathryn L Terry; Nils Schoof; Kevin H Eng; Alyssa Clay; Prashant K Singh; Janine M Joseph; Katja K H Aben; Hoda Anton-Culver; Natalia Antonenkova; Helen Baker; Yukie Bean; Matthias W Beckmann; Maria Bisogna; Line Bjorge; Natalia Bogdanova; Louise A Brinton; Angela Brooks-Wilson; Fiona Bruinsma; Ralf Butzow; Ian G Campbell; Karen Carty; Linda S Cook; Daniel W Cramer; Cezary Cybulski; Agnieszka Dansonka-Mieszkowska; Joe Dennis; Evelyn Despierre; Ed Dicks; Jennifer A Doherty; Andreas du Bois; Matthias Dürst; Doug Easton; Diana Eccles; Robert P Edwards; Arif B Ekici; Peter A Fasching; Brooke L Fridley; Yu-Tang Gao; Aleksandra Gentry-Maharaj; Graham G Giles; Rosalind Glasspool; Jacek Gronwald; Patricia Harrington; Philipp Harter; Hanis Nazihah Hasmad; Alexander Hein; Florian Heitz; Michelle A T Hildebrandt; Claus Hogdall; Estrid Hogdall; Satoyo Hosono; Edwin S Iversen; Anna Jakubowska; Allan Jensen; Bu-Tian Ji; Beth Y Karlan; Melissa Kellar; Joseph L Kelley; Lambertus A Kiemeney; Rüdiger Klapdor; Nonna Kolomeyevskaya; Camilla Krakstad; Susanne K Kjaer; Bridget Kruszka; Jolanta Kupryjanczyk; Diether Lambrechts; Sandrina Lambrechts; Nhu D Le; Alice W Lee; Shashikant Lele; Arto Leminen; Jenny Lester; Douglas A Levine; Dong Liang; Jolanta Lissowska; Song Liu; Karen Lu; Jan Lubinski; Lene Lundvall; Leon F A G Massuger; Keitaro Matsuo; Valeria McGuire; John R McLaughlin; Ian McNeish; Usha Menon; Joanna Moes-Sosnowska; Steven A Narod; Lotte Nedergaard; Heli Nevanlinna; Stefan Nickels; Sara H Olson; Irene Orlow; Rachel Palmieri Weber; James Paul; Tanja Pejovic; Liisa M Pelttari; Barbara Perkins; Jenny Permuth-Wey; Malcolm C Pike; Joanna Plisiecka-Halasa; Elizabeth M Poole; Harvey A Risch; Mary Anne Rossing; Joseph H Rothstein; Anja Rudolph; Ingo B Runnebaum; Iwona K Rzepecka; Helga B Salvesen; Eva Schernhammer; Kristina Schmitt; Ira Schwaab; Xiao-Ou Shu; Yurii B Shvetsov; Nadeem Siddiqui; Weiva Sieh; Honglin Song; Melissa C Southey; Ingvild L Tangen; Soo-Hwang Teo; Pamela J Thompson; Agnieszka Timorek; Ya-Yu Tsai; Shelley S Tworoger; Jonathan Tyrer; Anna M van Altena; Ignace Vergote; Robert A Vierkant; Christine Walsh; Shan Wang-Gohrke; Nicolas Wentzensen; Alice S Whittemore; Kristine G Wicklund; Lynne R Wilkens; Anna H Wu; Xifeng Wu; Yin-Ling Woo; Hannah Yang; Wei Zheng; Argyrios Ziogas; Simon A Gayther; Susan J Ramus; Thomas A Sellers; Joellen M Schildkraut; Catherine M Phelan; Andrew Berchuck; Georgia Chenevix-Trench; Julie M Cunningham; Paul P Pharoah; Roberta B Ness; Kunle Odunsi; Ellen L Goode; Kirsten B Moysich
Journal:  Oncotarget       Date:  2016-10-25

6.  Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma.

Authors:  Guoying Zou; Biqiong Ren; Yi Liu; Yin Fu; Pan Chen; Xiayu Li; Shudi Luo; Junyu He; Ge Gao; Zhaoyang Zeng; Wei Xiong; Guiyuan Li; Yumei Huang; Keqian Xu; Wenling Zhang
Journal:  Cancer Sci       Date:  2018-10-20       Impact factor: 6.716

7.  Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer.

Authors:  Ting Zhang; Qiong Pan; Songshu Xiao; Lijie Li; Min Xue
Journal:  Oncol Lett       Date:  2016-04-05       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.